C250-0425 Screening compound: N-(4-bromophenyl)-2-{[3-(3,4-dichlorophenyl)-8-methyl-1,4-diazaspiro[4.5]deca-1,3-dien-2-yl]sulfanyl}acetamide

C250-0425 Screening compound: N-(4-bromophenyl)-2-{[3-(3,4-dichlorophenyl)-8-methyl-1,4-diazaspiro[4.5]deca-1,3-dien-2-yl]sulfanyl}acetamide
C250-0425 Screening compound: N-(4-bromophenyl)-2-{[3-(3,4-dichlorophenyl)-8-methyl-1,4-diazaspiro[4.5]deca-1,3-dien-2-yl]sulfanyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C250-0425
N-(4-bromophenyl)-2-{[3-(3,4-dichlorophenyl)-8-methyl-1,4-diazaspiro[4.5]deca-1,3-dien-2-yl]sulfanyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C250-0425

Molecular Formula

C23H22BrCl2N3OS (C23 H22 BrCl2 N3 OS)

Compound Name

N-(4-bromophenyl)-2-{[3-(3,4-dichlorophenyl)-8-methyl-1,4-diazaspiro[4.5]deca-1,3-dien-2-yl]sulfanyl}acetamide

IUPAC name

N-(4-bromophenyl)-2-{[3-(34-dichlorophenyl)-8-methyl-14-diazaspiro[4.5]deca-13-dien-2-yl]sulfanyl}acetamide

SMILES

CC(CC1)CCC1(N=C1c(cc2)cc(Cl)c2Cl)N=C1SCC(Nc(cc1)ccc1Br)=O

InChI

InChI=1S/C23H22BrCl2N3OS/c1-14-8-10-23(11-9-14)28-21(15-2-7-18(25)19(26)12-15)22(29-23)31-13-20(30)27-17-5-3-16(24)4-6-17/h2-7,12,14H,8-11,13H2,1H3,(H,27,30)

InChI Key

AWIHXCSEZSUZMA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14757627

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

539.32

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

7.143

Distribution Coefficient, logD

7.143

Water Solubility, LogSw

-6.57

Polar Surface Area

40.230

Acid Dissociation Constant (pKa)

11.07

Base Dissociation Constant (pKb)

0.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

C250-0425 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C250-0425 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C250-0425?
Check Price and Availability of C250-0425, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C250-0425 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C250-0425
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C250-0425
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C250-0425 available by request